Cardiogenic shock occurs when the heart's muscular action fails to maintain adequate cardiac output (CO), a critical condition resulting from disorders affecting any functional part of the heart. This includes issues with the heart's valves, myocardial infarction, septal defects, arrhythmias, cardiomyopathy, or pulmonary hypertension. The situation is further complicated by a compensatory increase in systemic vascular resistance (SVR) as the body attempts to correct the reduced CO. Key symptoms of cardiogenic shock include hypotension, decreased urinary output, and altered mental status, highlighting the severe impairment of the heart's pumping ability.
The treatment for this kind of shock focuses on enhancing cardiac output (CO) and reducing systemic vascular resistance (SVR), rather than administering large amounts of fluid. Key interventions include the use of inotropic agents such as dobutamine, dopamine, and milrinone, which help increase CO and decrease SVR. Focus should also be on administering oxygen, reducing myocardial oxygen demand, and administering antiarrhythmics for any underlying arrhythmias.
